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Abstract
Objectives: Transient receptor potential vanilloid 1 (TRPV1) -positive sensory nerves are widely distributed in the kidney,
suggesting that TRPV1-mediated action may participate in the regulation of renal function under pathophysiological
conditions. Stimulation of TRPV1 channels protects against ischemia/reperfusion (I/R)-induced acute kidney injury (AKI).
However, it is unknown whether inhibition of these channels is detrimental in AKI or not. We tested the role of TRPV1
channels in I/R-induced AKI by modulating these channels with capsaicin (TRPV1 agonist), capsazepine (TRPV1 antagonist)
and using Trpv12/2 mice.
Methods and Results: Anesthetized C57BL/6 mice were subjected to 25 min of renal ischemia and 24 hrs of reperfusion.
Mice were pretreated with capsaicin (0.3 mg/kg body weight) or capsazepine (50 mg/kg body weight). Capsaicin
ameliorated the outcome of AKI, as measured by serum creatinine levels, tubular damage,neutrophil gelatinase-associated
lipocalin (NGAL) abundance and Ly-6B.2 positive polymorphonuclear inflammatory cells in injured kidneys. Neither
capsazepine nor deficiency of TRPV1 did deteriorate renal function or histology after AKI. Measurements of endovanilloids in
kidney tissue indicate that 20-hydroxyeicosatetraeonic acid (20-HETE) or epoxyeicosatrienoic acids (EETs) are unlikely
involved in the beneficial effects of capsaicin on I/R-induced AKI.
Conclusions: Activation of TRPV1 channels ameliorates I/R-induced AKI, but inhibition of these channels does not affect the
outcome of AKI. Our results may have clinical implications for long-term safety of renal denervation to treat resistant
hypertension in man, with respect to the function of primary sensory nerves in the response of the kidney to ischemic
stimuli.
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Introduction
The kidneys are profusely innervated organs in which renal
adrenergic neurons supply all the segments of renal vasculature
and are distributed throughout the renal cortex, outer stripe of the
medulla, juxtamedullary region of the inner cortex and the renal
tubules [1]. Transient receptor potential cation channel subfamily
V member 1 (TRPV1)-positive sensory nerves are widely
distributed in the kidney, suggesting that TRPV1-mediated action
may participate in the regulation of renal function under
pathophysiological conditions [2]. Indeed, sodium excretion in
response to sodium loading is impaired in salt-sensitive hyperten-
sion induced by surgical sensory denervation or by sensory nerve
degeneration following capsaicin treatment [3]. Blockade of
TRPV1 increases blood pressure in Wistar or Dahl salt-resistant
rats fed a high but not normal salt diet suggesting that high salt
intake may activate TRPV1 conferring a protective effect [4].
Chronic TRPV1 stimulation by systemic application of capsaicin
lowers systemic blood pressure with possible involvement of
TRPV1 channels in sensory nerves and blood vessels [5].
Catheter-based renal denervation (RDN) is a novel technique to
lower resistant hypertension specifically targeting renal sympa-
thetic nerves [6]. This procedure is expected to affect the function
of TRPV1-rich primary sensory nerves of the renal sympathetic
nervous system. Of note, renal sympathetic nerves and circulating
catecholamines are believed to be involved in the development of
the progressive renal tissue injury accompanying ischemic acute
renal failure [7][8]. However, experimental evidence concerning
primary sensory nerves of renal sympathetic nervous system and
its contribution to the pathogenesis of ischemia/reperfusion (I/R)-
induced acute kidney injury (AKI) is confounding and warrants
further investigation.
Three studies have reported that systemic activation of TRPV1
by capsaicin ameliorates I/R-induced renal dysfunction [9][10]
[11]. Capsazepine is a potent blocker of TRPV1 channels [12]
[13], but this drug has not been studied in AKI. Deficiency of
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TRPV1 genes in mice has been shown to impair the recovery
process of I/R induced cardiac dysfunction [14]. It is unknown
whether inhibition of TRPV1 channels is detrimental in AKI or
not. Knowledge of these effects may have clinical implications to
understand the kidneys’ ability to respond to ischemic stimuli after
RDN therapy in man, including the long-term safety profile of this
procedure.
In this study, we tested the role of TRPV1 channels in
experimental I/R induced AKI in mice by stimulating and
inhibiting these channels with capsaicin, capsazepine, respectively,
and using Trpv12/2 mice. In order to provide possible
mechanistic insights, we measured endovanilloids, such as 20-
hydroxyeicosatetraeonic acid (20-HETE), anandamide, epoxyei-
cosatrienoic acids and epoxy-9Z-octadecenoic acids in injured
kidneys, which can activate TRPV(1) channels [15] [16][17]
[18][19] and are implicated in AKI [20] [21][22] [23]. Our results
support the view that activation of TRPV1 channels ameliorates
I/R–induced AKI. In contrast to our expectations, we found that
inhibition or genetic ablation of TRPV1 does not affect the
outcome of AKI. Our findings provide novel insights into the role
of TRPV1-rich primary sensory nerves in AKI and have
implications for safety of renal denervation in man.
Materials and Methods
Animals
Experiments were performed using 2–3-month-old male
C57BL/6 wild-type mice and Trpv12/2 mice (Jackson Labora-
tories, Bar Harbor, Main, USA). Mice were housed under a
12 hr/12 hr day/night cycle with free access to food and water.
The investigation was approved by the local government
authorities and conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health and the ethics policies of our University and the Land
Berlin. The protocol was approved by the Committee on the
Ethics of Animal Experiments of the Charite´ and Land Berlin
(Permit Number: 0065/11).
Animal model of renal ischemia/reperfusion
We performed ischemia/reperfusion (I/R)-induced acute kid-
ney injury (AKI) similarly as previously described for rats [22].
Briefly, anaesthesia was performed with isoflurane (2.5%) in air
(350 ml/min). A temperature controller with heating pad (TCAT-
2, Physitemp Instruments Inc, Clifton, NJ, USA) was used to keep
the animal’s body temperature stable during surgery. Rectal body
temperature was continuously monitored using a sensor based on
thermistors. During surgery, rectal body temperature values (max-
min) were as follows: I/R control, 37.8–35.8uC, n = 8; capsaicin
(0.3 mg/kg) treatment I/R, 37.8–35.4uC, n = 13; capsazepine
(50 mg/kg) treatment I/R, 37.6–35.1uC, n = 10; Trpv12/2 I/R,
37.5–35.6uC, n = 13. I/R injury was induced after right unine-
phrectomy by clipping the pedicles of the remaining left kidney for
25 minutes with non-traumatic aneurysm clip (FE690K, Aesculap
AG, Tuttlingen, Germany). Reperfusion was confirmed visually.
After surgery mice had free access to water and chow.
Perioperative hydration by applying body-warm sterile physiolog-
ical saline solution and analgesia by subcutaneous buprenorphin
(0.1 mg/kg) was provided for each mouse. Three groups of mice
were intraperitoneally injected either with saline (control group),
with the capsaicin (0.3 mg/kg body weight) or capsazepine
(50 mg/kg body weight) 30 min before I/R injury. After 24 hour
reperfusion time the mice were sacrificed, and the kidney and
blood was collected for further analysis.
Collected blood was centrifuged at 2,000 g for 10 min for
examination of serum creatinine. Serum levels of creatinine were
measured by an autoanalyzer (Beckman Analyzer; Beckman
Instruments, Munich, Germany). The kidneys were immersed in
4% buffered formalin for histopathological and immunohisto-
chemical examination. In total 51 mice underwent surgery; two of
them died during the perioperative period and were excluded from
the study.
Histological evaluation of the kidneys
All kidney samples were immersed in 4% buffered formalin.
Samples were processed for histology in an automatic device.
Processing consisted of three immersions (1 h each) in absolute
ethyl alcohol and three immersions (1 h each) in xylene at room
temperature, followed by immersion in two vessels (1 h in each)
containing liquid paraffin at approximately 60uC.
After embedding, the samples were blocked in paraffin and cut
into 1.5-mm sections using a microtome. Sections were mounted
on slides, deparaffinized in xylene and stained with hematoxylin
and eosin (H&E), periodic acid-Schiff (PAS).
Histomorphometric analysis was performed to semi-quantitively
evaluate the score of acute tubular necrosis (ATN) in mouse renal
parenchyma using H&E staining. Slides were examined under a
light microscope (200X magnification). Examination was per-
formed by a local nephropathologist, who was blinded to the
experimental assignments. Acute tubular injury (ATI) was
observed in this study to assess the reversible tubular damage
due to ischemia, the histologic features of ATI included one or
more of the following lesions: tubular epithelial swelling with
lucency of the cytoplasm, loss of brush border, luminal dilatation
with simplification of the epithelium, and cytoplasmic vacuoliza-
tion. Acute tubular necrosis (ATN) was also evaluated, which was
indicated by patchy loss of tubular epithelial cells with resultant
gaps and exposure of denuded basement membrane, evidence of
cellular regeneration, as well as obliterated tubular hyaline and/or
granular casts. The histological findings were graded from 0 to 3
according to the distribution of lesions: 0 = none; 1 =,25%;
2 = 25–50%; 3 =.50% [24].
Neutrophil gelatinase-associated lipocalin (NGAL)
immunohistochemistry
NGAL immunohistochemistry was performed on paraffin-fixed
kidney sections. Non-specific binding sites were blocked with 10%
normal donkey serum for 30 min. Then sections were incubated
with the NGAL antibody (dilution: 1:300) overnight at 4uC in a
humid chamber. For fluorescence visualization of bound primary
antibody, sections were further incubated with Cy3-conjugated
secondary antibody for 1 h in a humid chamber at room
temperature [25]. Specimens were analyzed using a Zeiss
Axioplan-2 imaging microscope with the computer program
AxioVision 4.8 (Zeiss, Jena, Germany). The investigator had no
knowledge of the treatment group assignment. NGAL positive
area were analysed by ImageJ (NIH, USA) using thresholding
method.
Immunohistochemical detection of Ly-6B.2 positive cells
Immunohistochemical staining of Ly-6B.2 positive cells was
performed on paraffin-fixed kidney sections. Antigen retrieval was
performed by incubating sections for 10 minutes at 37uC in a
trypsin solution (Sigma). After cooling down non-specific binding
sites were blocked with 10% normal donkey serum for 30 min.
Then sections were incubated with the rat anti mouse Ly-6B.2
monoclonal antibody, clone 7/4 (dilution: 1:300) overnight at 4uC
TRPV1 in Acute Kidney Injury
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in a humid chamber. For fluorescence visualization of bound
primary antibody, sections were further incubated with Cy3-
conjugated secondary antibody for 1 h in a humid chamber at
room temperature [17]. Specimens were analyzed using a Zeiss
Axioplan-2 imaging microscope with the computer program
AxioVision 4.8 (Zeiss, Jena, Germany). The investigator had no
knowledge of the treatment group assignment. Ly-6B.2 positive
cells were counted in per field view by a counter. (400X
magnification).
Determination of endovanilloids
Endovanilloid profiles were measured by Lipidomics GmbH
(Berlin, Germany). Briefly, kidney tissue samples were subjected to
alkaline hydrolysis and subsequent solid phase extraction was
performed as described previously [26] [27]. LC-MS/MS analysis
of the extracted metabolites was performed using the Agilent 6460
Triplequad mass spectrometer with Jetstream ion source (Agilent
Technolgies, Santa Clara, CA) coupled with Agilent 1200 HPLC
(degasser, binary pump, well plate sampler, thermostated column
compartment). The HPLC system was equipped with a Phenom-
enex Kinetex Column (150 mm62.1 mm, 2.6 mm, Phenomenex,
Aschaffenburg, Germany). Tissue samples were analysed in two
separate series of experiments, each using independent internal
standards (deuterated eicosanoids and metabolites) added to the
samples before extraction for the quantification of groups of
similar metabolites. The first series of experiments determined
eicosanoid profiles in non-ischemic (Control) and ischemic (I)
kidneys 25 min after ischemia (without reperfusion) from a group
of wild-type mice with ischemia (I)-induced AKI; the second series
of experiments determined the profiles in non-ischemic (I/R
Control) and ischemic (I/R) kidneys after 25 min of ischemia and
24 hours of reperfusion from the above described four groups of
mice with I/R-induced AKI, namely control wild-type mice,
capsaicin treated wild-type mice, capsazepine treated wild-type
mice, and Trpv12/2 mice.
Materials
Capsaicin and capsazepine were obtained from Sigma-Aldrich
Chemie GmbH (Munich, Germany). NGAL antibody was
obtained from R&D systems (AF1857). Rat anti Mouse Ly-6B.2
monoclonal antibody, clone 7/4 was obtained from AbD Serotec
(Puchheim, Germany). Cy3-conjugated secondary antibody was
obtained from Jackson ImmunoResearch (West Grove, USA).
Statistics
All data are given as mean 6 SEM of n experiments. Statistical
analysis of data was performed using one-way ANOVA using
ORIGIN 6.0 software. A P value of less than 0.05 was considered
statistically significant.
Results
Serum creatinine levels after I/R-induced AKI
Mice treated with capsaicin (0.3 mg/kg) had lower serum
creatinine levels after I/R-induced AKI compared to control mice
after renal I/R injury (Figure 1, 154.3566.58 mmol/L, n = 13, vs
190.8466.13 mmol/L, n = 8, respectively, P,0.05). However,
mice treated with capsazepine (50 mg/kg; Figure 1,
173.51610.78 mmol/L, n = 10, P.0.05) showed serum creatinine
levels after AKI similar to control mice after renal I/R injury.
Trpv12/2 mice showed an increase in serum creatinine levels
after I/R induced AKI (Figure 1, 192.5166.76 mmol/L, n = 13,
P.0.05) similar to control mice after renal I/R injury.
Tubular damage scores
Capsaicin (0.3 mg/kg) ameliorated I/R-induced tubular dam-
age compared to control mice after renal I/R injury (Figure 2A,
ATN scores 2.060.27, n = 13, vs 3.060, n = 8, respectively, P,
0.05). ATN score in mice treated with capsazepine (50 mg/kg)
(Figure 2A, ATN 2.4560.31, n = 10, P.0.05) was not different
compared to control mice after renal I/R injury. Trpv12/2 mice
after AKI showed a tubular damage score similar to control mice
after renal I/R injury (Figure 2A, ATN 2.8360.17, n = 13, P.
0.05).
NGAL abundance in the kidney after AKI
Mice treated with capsaicin (0.3 mg/kg) showed lower NGAL
abundance, an early biomarker of AKI, in kidneys after I/R injury
compared to control mice after AKI (Figure 3A, 5.4461.13%,
n = 13, vs 12.7862.40%, n = 8, respectively, P,0.05). Kidneys of
mice treated with capsazepine (50 mg/kg, Figure 3A,
8.5662.57%, n = 10, P.0.05) or Trpv12/2 mice (Figure 3A,
7.2561.67%, n = 13, P.0.05) showed NGAL abundance similar
to control mice after I/R injury.
Ly-6B.2 positive cells
Ly-6B.2 is a ,25–30 kDa GPI-anchored, heavily glycosylated
protein expressed on neutrophils, inflammatory monocytes and
some activated macrophages. Figure 4 shows that mice treated
with capsaicin (0.3 mg/kg) showed less Ly-6B.2 positive cells in
kidneys after I/R injury compared to control mice after AKI
(Figure 4A, 17.9564.54 per field view, n = 5 vs 41.6266.23 per
field view, n = 4, respectively, P,0.05). Kidneys of mice treated
with capsazepine (50 mg/kg, Figure 4A, 47.40610.7 per field
view, n = 5, P.0.05) or Trpv12/2 mice (Figure 4A, 31.965.47,
n = 4, P.0.05) showed Ly-6B.2 positive cells similar to control
mice after I/R injury.
Figure 1. Serum creatinine levels in mice subjected to renal I/R
injury were ameliorated by pretreatment with capsaicin, but
not capsazepine or genetic ablation of TRPV1. Control, control
mice that underwent sham surgery (nephrectomy) without I/R. I/R
Control, control mice that underwent renal I/R injury. Capsaicin I/R,
wild-type mice pretreated with capsaicin followed by renal I/R injury.
Capsazepine I/R, wild-type mice pretreated with capsazepine followed
by renal I/R injury. Trpv12/2 mice that underwent renal I/R injury. *P,
0.05. P.0.05; not significant.
doi:10.1371/journal.pone.0109842.g001
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Figure 2. Amelioration of tubular damage score of I/R-induced AKI by pretreatment of mice with capsaicin, but not with
capsazepine or genetic ablation of TRPV1. Panel A: Tubular damage scores of ipsilateral kidneys (I/R Control) and kidneys after I/R (I/R) of
control mice. Tubular damage scores of ipsilateral kidneys (Capsaicin C) and kidneys after I/R injury (Capsaicin I/R) of mice pretreated with capsaicin.
Tubular damage scores of ipsilateral kidneys (Capsazepine C) and kidneys after I/R injury (Capsazepine I/R) of mice pretreated with capsazepine.
Tubular damage scores of ipsilateral kidneys (Trpv12/2 C) and kidneys after I/R injury (Trpv12/2 I/R) of Trpv12/2 mice. Scores of ipsilateral control
kidneys without I/R injury were all 0. *, P,0.05. P$0.05; not significant. Panel B: Histological sections. (a) I/R Control, histology of ipsilateral kidney
before renal I/R injury of a control mouse. (b) I/R, histology of kidney after I/R injury of a control mouse. The section shows acute tubular necrosis
characterized by loss of tubular epithelial cells (arrow) and shedding of the brush border (asterisk). (c) Capsaicin I/R, histology of kidney after I/R injury
of a mouse pretreated with capsaicin. Acute tubular necrosis (arrow). (d) Trpv12/2 I/R, histology of kidney after I/R injury of a Trpv12/2 mouse.
Acute tubular necrosis (arrow) and shedding of the brush border (asterisk). Scale bar 100 mm. Magnification6 200.
doi:10.1371/journal.pone.0109842.g002
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Figure 3. NGAL abundance in the kidney was lower in I/R-induced AKI in mice treated with capsaicin, but not with capsazepine or in
Trpv12/2mice. Panels A: NGAL abundance of ipsilateral kidneys (I/R Control) and kidneys after I/R (I/R) injury of control mice. NGAL abundance of
ipsilateral kidneys (Capsaicin C) and kidneys after I/R injury (Capsaicin I/R) of mice pretreated with capsaicin. NGAL abundance of ipsilateral kidneys
(Capsazepine C) and kidneys after I/R injury (Capsazepine I/R) of mice treated with capsazepine. NGAL abundance of ipsilateral kidneys (Trpv12/2 C)
and kidneys after I/R injury (Trpv12/2 I/R) of Trpv12/2 mice. *, P,0.05. P.0.05; not significant. Panels B: Immunohistological sections. (a) I/R
Control, images of NGAL negative staining of ipsilateral kidney before renal I/R injury of a control mouse. (b) I/R, intense renal NGAL staining after I/R
injury of a control mouse. (c) Capsaicin I/R, renal NGAL staining after I/R injury of a mouse pretreated with capsaicin. (d) Trpv12/2 I/R, renal NGAL
staining after I/R injury of a Trpv12/2 mouse. Scale bar 100 mm. Magnification6200.
doi:10.1371/journal.pone.0109842.g003
TRPV1 in Acute Kidney Injury
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Endovanilloids after I-induced AKI
Figure 5A shows that levels of epoxides of arachidonic acid,
namely the epoxyeicosatrienoic acid (EET) regioisomers 5,6-EET,
8,9-EET, 11,12-EET, 14,15-EET, were relatively high in non-
ischemic kidneys. Similar findings were observed for the 9,10- and
11,12-epoxides of linoleic acid (9,10-EpOME,11,12-EpOME).
Figure 5B shows that ischemia does slightly increased release of
EETs, 20-HETE, and 9,10-DiHOME. Diols of these metabolites
(5,6-DHET, 8,9-DHET, 11,12-DHET, 14,15-DHET, 9,10 Di-
HOME, 12,13-DiHOME) were present, but at negligibly small
levels. Anandamide was present only in bound form at relatively
high levels, but decreased during acute ischemia (panel A).
Endovanilloids after I/R-induced AKI
Figure 6 (panels A–L) shows that I/R increased levels of EETs,
DHETs, EpOMEs and DiHOMEs in injured kidneys. However,
the increase in EETs/DHETs was neither seen in injured kidneys
of capsaicin treated mice nor injured kidneys of Trpv12/2 mice,
which indicates that EETs are unlikely involved in the beneficial
effects of capsaicin on outcome of I/R –induced AKI.
Figure 4. Lower Ly-6B.2 positive cells in the kidneys after I/R-induced AKI in mice treated with capsaicin, but not with capsazepine
or in Trpv12/2 mice. Ly-6B.2 positive cells were analyzed in the medulla (red color in panels B, marked by arrows). Panels A: Ly-6B.2 positive cells
per field view in ipsilateral kidneys (I/R Control) and kidneys after I/R (I/R) injury of control mice. Ly-6B.2 positive cells in ipsilateral kidneys (Capsaicin
C) and kidneys after I/R injury (Capsaicin I/R) of mice pretreated with capsaicin. Ly-6B.2 positive cells in ipsilateral kidneys (Capsazepine C) and kidneys
after I/R injury (Capsazepine I/R) of mice treated with capsazepine. Ly-6B.2 positive cells in ipsilateral kidneys (Trpv12/2 C) and kidneys after I/R injury
(Trpv12/2 I/R) of Trpv12/2 mice. *, P,0.05. P.0.05; not significant. Panels B: Immunohistological sections. (a) I/R Control, images of Ly-6B.2
positive cells in ipsilateral kidney before renal I/R injury of a control mouse. (b) I/R, Ly-6B.2 positive cells in a kidney after I/R injury of a control mouse.
(c) Capsaicin I/R, Ly-6B.2 positive cells in a kidney after I/R injury of a mouse pretreated with capsaicin. (d) Trpv12/2 I/R, Ly-6B.2 positive cells in a
kidney after I/R injury of a Trpv12/2 mouse. Scale bar 50 mm. Magnification6400.
doi:10.1371/journal.pone.0109842.g004
TRPV1 in Acute Kidney Injury
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Figure 6 (panels I,J) shows that I/R increased levels of both
9,10- and 11,12-epoxides of linoleic acid (9,10-EpOME,11,12-
EpOME) in kidneys. TRPV1 deficiency did not affect 9,10-
EpOME and 11,12-EpOME levels in non-injured kidneys and in
kidneys after I/R injury (panels I,J). In contrast, capsaicin reduced
levels of 9,10-EpOME and 11,12-EpOME and their diols (panels
K,L) in non-injured kidneys and prevented increases in 9,10-
EpOME and 11,12-EpOME in I/R-injured kidneys (panels I,J).
Together, the data indicate capsaicin reduces EpOMEs/Di-
HOMEs in kidneys in vivo through activation of TRPV1, an
effect that is preserved in kidneys after I/R injury.
Figure 6 (panel M) shows that neither TRPV1 activation by
capsaicin nor deficiency of TRPV1 affected levels of 20-HETE in
non-injured kidneys. Capsaicin did not affect the increase in 20-
HETE in injured kidneys after I/R; nevertheless, TRPV1
channels might be involved in I/R-induced increase in 20-HETE
levels since Trpv12/2 kidneys showed no increase in 20-HETE.
Of note, TRPV1 activation by capsaicin increased anandamide
levels in non-injured kidneys, whereas deficiency of TRPV1 was
associated with reduced levels (Figure 6, panel N). Although I/R
resulted in decreased levels of anandamide in injured kidneys of
wild-type mice, this effect was inhibited by capsaicin but not by
TRPV1 deficiency. Together, the data suggest that pharmacolog-
ical TRPV1 activation by capsaicin can increase levels of
anandamide in injured kidneys after I/R.
Body temperature
There were no differences in core body temperature between
the verum groups and the control group during the perioperative
procedure (see methods).
Discussion
In the present study, we showed for the first time that I/R–
induced AKI is not affected by inhibition of TRPV1 channels.
AKI was assessed by three parameters: by measuring serum
creatinine, by scoring tubular damage and by NGAL/Ly-6B.2
immunohistochemistry. Our data are consistent with previous
results demonstrating that systemic activation of TRPV1 channels
by capsaicin or other agonists mitigates I/R-induced AKI [9]
[10][11]. Our results may have clinical implications for treatment
of resistant hypertension by denervation of renal primary sensory
nerves in man, i.e. safety issues of this procedure in patients who
undergo renal denervation and which is increasingly used in
Western countries [28]. There is concern that this procedure may
cause harm on the kidney’s ability to respond to ischemic stimuli
later in life of these patients [15], in particular since clinical long-
term results of patients who underwent this procedure are not
available [29].
Ischemic acute renal failure is a frequent clinical syndrome with
a high morbidity and mortality [30]. Reperfusion of previously
ischemic renal tissue initiates a series of complex cellular events
that results in injury and the eventual death of renal cells from a
combination of apoptosis and necrosis [31]. Recent pre-clinical
data indicate that activators of TRPV1 can improve the outcome
of ischemic AKI [9][10] [11]. Ueda et al. observed that capsaicin
(3, 10, and 30 mg/kg orally) 30 minutes before ischemia dose-
dependently attenuated I/R-induced renal dysfunction [10].
Mizutani, et. al. suggested that activation of sensory neurons
could reduce I/R–induced AKI by attenuating inflammatory
responses through enhanced endothelial PGI2 production [32].
Kyoko U, et.al. proposed inhibition of inflammatory cells by
capsaicin in this response [9]. Our data on Ly-6B.2 immunohis-
tochemistry support this notion. However, it has not been studied
whether direct inhibition of these channels is detrimental in AKI
or not. In present study, we used a solitary kidney I/R mouse
model of AKI to study the effects of pharmacological inhibition of
TRPV1 channels (using capsazepine) and genetic ablation of
TRPV1 (using Trpv12/2 mice). For comparison, we studied the
effects of TPRV1 stimulation (using the TRPV1 agonist capsaicin).
We found that inhibition of TRPV1 channels does not affect the
outcome of I/R-induced renal injury. Three injury parameters
demonstrated that TRPV1 inhibition does not cause harm in I/R
-induced AKI. Although the relatively high concentration of
capsaicin used in this study to activate TRPV1 in vivo may have
additional effects not related to TRPV1, these three injury
parameters demonstrated a beneficial role of capsaicin in I/R-
induced AKI as previously reported by other groups for capsaicin
and other TRPV1 agonists [9] [10][11].
Of note, Ueda K, et al. proposed that capsazepine could be an
inappropriate drug to study the role of TRPV1 inhibition in I/R-
induced renal injury since this drug was not able to antagonize
TRPV1 agonist-induced renoprotective effects [9]. As a result, this
group did not study directly the effects of capsazepine on I/R-
Figure 5. Eicosanoids and anandamide levels in non-ischemic
(control) and ischemic (I) kidneys of (WT) wild-type mice after I-
induced AKI. 5,6-EET, 5,6-epoxyeicosatrienoic acid; 8,9-EET, 8,9-
epoxyeicosatrienoic acid; 11,12-EET, 11,12-epoxyeicosatrienoic acid;
14,15-EET, 14,15-epoxyeicosatrienoic acid; 5,6-DHET, 5,6-dihydroxyeico-
sastrienoic acid; 8,9-DHET, 8,9-dihydroxyeicosastrienoic acid; 11,12-
DHET, 11,12-dihydroxyeicosastrienoic acid; 14,15-DHET, 14,15-dihydrox-
yeicosastrienoic acid; 20-HETE, 20-hydroxyeicosatetraenoic acid; 9,10-
EPOME, 9(10)epoxy-9Z-octadecenoic acid; 12,13-EPOME, 12(13)epoxy-
9Z-octadecenoic acid; 9,10-DIHOME, 9(10)-dihydroxy-12Z-octadecenoic
acid; 9,10-DIHOME, 9(10)-dihydroxy-12Z-octadecenoic acid. n = 5 in
each group.
doi:10.1371/journal.pone.0109842.g005
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induced AKI. We used a genetic approach (Trpv12/2 mice) and
pharmacological testing (capsazepine) to study the role TRPV1
inhibition in I/R-induced AKI. Our results demonstrate that AKI
is not affected by TRPV1 inhibition. Moreover, tubular damage,
NGAL scores and Ly-6B.2 positive cells per field view were not
increased in non-ischemic ipsilateral kidneys of capsazepine
(50 mg/kg) treated mice (060 (n = 10), 0.00360.002% (n = 10)
and 0.2260.22(n = 5), respectively, P.0.05). The latter data
demonstrate that capsazepine at 50 mg/kg is not toxic to the
mouse kidney itself.
On the other hand, reduction in body temperature has been
shown to protect the kidney from ischemic injury [33]. Of note,
TRPV1 agonists can cause hypothermia, while TRPV1 antago-
nists are known to induce hyperthermia in multiple species (rats,
dogs, and monkeys), demonstrating that TRPV1 function in
thermoregulation [34]. Thus, changes in body temperature in
response to capsaicin and/or capsazepine may be involved in
effects of these agents on the outcome of AKI. In the present study,
surgical procedures were done under body temperature-controlled
conditions. Our results demonstrate that changes of body
temperature are neither responsible for the protective effects of
capsaicin nor for the lack of effects of TRPV1 inhibition on the
outcome of I/R-mediated AKI.
In conclusion, pre-ischemic inhibition of TRPV1 in mice does
not affect the outcome of I/R-induced renal injury, while
activation of these channels mitigates AKI. The mechanisms of
the beneficial effects of capsaicin are unknown, but are likely
caused via TRPV1-mediated mechanisms in afferent sensory
nerves and inhibition of inflammatory responses [9] [10] [11].
Consistently, we found less Ly-6B.2 positive cells in kidneys after
I/R of capsaicin treated mice. The beneficial effects of capsaicin
may involve release of a substance from TRPV1-expressing nerve
endings that exerts a protective action against ischemia/reperfu-
sion-induced kidney injury. Somatostatin is an interesting candi-
date [35][36], which can act as autocrine ‘‘endovannilloid’’ to
modulate peripheral TRPV1 receptors [37] [38], but so far has
not been implicated in AKI. Our measurements of other
endovanilloids [19] in kidney tissue demonstrate that anandamide
and/or EpOMEs/DiHOMES, but not 20-HETE or EETs, are
possible candidates to be involved in the beneficial effects of
capsaicin on the outcome of I/R-induced AKI. Although
EpOMEs/DiHOMES [20] [23] and anandamide analogs/recep-
tor agonists [39] have been recently suggested to represent novel
therapeutic targets in AKI, our data suggest that future studies on
their role in AKI should consider pathways of TRPV1 signaling to
understand their molecular actions.
Figure 6. Eicosanoids and anandamide levels in non-ischemic (I/R Control) and ischemic (I/R) kidneys of wild-type mice after I/R-
induced AKI, in non-ischemic (Capsaicin C) and ischemic (Capsaicin I/R) kidneys of wild-type mice after I/R-induced AKI, and in non-
ischemic (Trpv12/2 C) and ischemic (Trpv12/2 I/R) kidneys of Trpv12/2 mice after I/R-induced AKI. n.8 in each group.
doi:10.1371/journal.pone.0109842.g006
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Our data suggest that lack of functional TRPV1 channels does
not cause harm to the kidney’s ability to respond to support
ischemic stimuli. These data may have important implications for
interpretation of data on long-term safety of RDN in man. Since
this procedure impairs responsiveness of TRPV1-rich renal
primary sensory nerves, our data will contribute to the validity
of arguments aimed to address the question whether this
procedure is effective and safe to treat resistant hypertension or
even to do nothing, than to risk causing more harm than good.
Moreover, discovery of novel pharmacological TRPV1 modula-
tors may be a successful strategy for better treatment of acute
kidney failure.
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